Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Foldrx Pharmaceuticals

Foldrx Pharmaceuticals

Foldrx Pharmaceuticals is a company that develops disease modifying drug therapies.

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
Acquisition Transaction
‌
Acquisition of Foldrx Pharmaceuticals by Pfizer
‌
Acquisition of Foldrx Pharmaceuticals by Pfizer
AngelList URL
angel.co/foldrx-pha...maceuticals
B2X
B2B
B2B
CEO
Richard Labaudinière
Richard Labaudinière
CIK Number
1,274,481
Company Operating Status
Active
Crunchbase URL
crunchbase.com/organiz...euticals
Date Incorporated
2004
Founder
Susan Lindquist
Susan Lindquist
‌
Jeffery W. Kelly
Full Address
100 Acorn Park Dr # 5 Cambridge​, MA, 02140-2303 United States
Industry
Biotechnology
Biotechnology
Technology
Technology
Biology
Biology
Genetics
Genetics
Healthcare
Healthcare
Investors
TPG Growth
TPG Growth
Alta Partners
Alta Partners
Novartis Venture Fund
Novartis Venture Fund
Morgenthaler Ventures
Morgenthaler Ventures
Novo Ventures
Novo Ventures
HealthCare Ventures
HealthCare Ventures
Eight Roads Ventures
Eight Roads Ventures
F-Prime Capital Partners
F-Prime Capital Partners
‌
Original Investors
Latest Funding Round Date
June 15, 2010
Latest Funding Type
Series B Round
Series B Round
LinkedIn URL
@company/foldrx-pharmaceuticals/about
Location
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
Cambridge, Massachusetts
Cambridge, Massachusetts
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
2
Total Funding Amount (USD)
88,000,000
Official Website
foldrx.com
Wellfound ID
foldrx-pharmaceuticals

Find more companies like Foldrx Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.